Pharma major Dr. Reddy’s Laboratories and Nasdaq-listed global biotech firm Alvotech will co-develop, manufacture and commercialise a biosimilar candidate to Merck’s cancer drug Keytruda ...

Iceland based Biotech company Alvotech and Dr Reddy’s Laboratories have entered into a collaboration and license agreement to co-develop, manufacture and commercialise a biosimilar candidate ...

Alvotech and Dr Reddy’s Laboratories announced today they have entered a collaboration agreement to co-develop, manufacture and commercialise a biosimilar candidate to Keytruda (pembrolizumab ...

Dr Reddy’s has partnered with Alvotech. (Image: X/Twitter) Dr Reddy’s Laboratories announced that it has partnered with Alvotech, a global biotech firm focused on biosimilar medicines. The two ...

Dr. Reddy's Laboratories and Alvotech have partnered to co-develop, manufacture, and commercialize a biosimilar of Keytruda (pembrolizumab), a significant cancer treatment. This collaboration aims ...

Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to co-develop and commercialize a biosimilar of Merck's (NYSE:MRK ...

Shares of Dr. Reddy’s Laboratories surged 4 percent to Rs 1,303 on June 5, making it one of the top gainers on the Nifty 50. The rally followed the company’s announcement of a strategic ...

Former Philadelphia Eagles safety Chauncey Gardner-Johnson hasn't been thrilled that the team traded him to the Houston Texans fresh off a Super Bowl victory last season. Especially considering ...

Sources: Quinton Crawford — head coach who guided Stockton Kings to the G League championship — has agreed to join Portland Trail Blazers as an assistant under Chauncey Billups. pic.twitter ...

A Long Island speech pathologist said a pioneering bio implant stopped her “horrific ... immune system through the vagus nerve,” said Dr. Kevin Tracey, president and CEO of Northwell ...

In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development ...